The new Veterinary Medicines Regulation: rising to the challenge.

Autor: More SJ; Centre for Veterinary Epidemiology and Risk Analysis, UCD School of Veterinary Medicine, University College Dublin, Belfield, Dublin, D04 W6F6, Ireland. simon.more@ucd.ie.; UCD School of Veterinary Medicine, University College Dublin, Belfield, Dublin, D04 W6F6, Ireland. simon.more@ucd.ie., McCoy F; Animal Health Ireland, 4-5 The Archways, Carrick on Shannon, Co., Leitrim, N41 WN27, Ireland., McAloon CI; UCD School of Veterinary Medicine, University College Dublin, Belfield, Dublin, D04 W6F6, Ireland.
Jazyk: angličtina
Zdroj: Irish veterinary journal [Ir Vet J] 2022 Feb 03; Vol. 75 (1), pp. 2. Date of Electronic Publication: 2022 Feb 03.
DOI: 10.1186/s13620-022-00209-6
Abstrakt: This article focuses on the new Veterinary Medicines Regulation, which is applicable across all Member States of the European Union, including Ireland, from 28 January 2022. From this date, prophylactic use of antimicrobials (AMs) in groups of animals is banned, metaphylactic use in groups of animals is restricted, and certain AMs are reserved for humans only. In the Irish dairy industry, as elsewhere, successful implementation of the Regulation will require a high level of mastitis control across all herds, and measures to support high standards in antibiotic stewardship. National actions will be critical, to support optimal mastitis control throughout the national herd. For private veterinary practitioners (PVPs), the Regulation will lead to specific prescribing changes, including the requirement to shift from blanket to selective dry cow therapy. Further, prescribing choices will need to be guided by the categorisation for AMs developed by the European Medicines Agency (EMA). More broadly, the Regulation requires a fundamental shift in thinking both in terms of AM usage and of the role of the PVP. Given the close association between mastitis control and intramammary AM stewardship, it is imperative that prescribing and mastitis control decisions are made concurrently. A herd health approach will be critical, within a Client-Patient-Practice Relationship as outlined by the Veterinary Council of Ireland. On those farms with sub-optimal mastitis control, mastitis issues need to be sustainably resolved. A detailed farm investigation by the PVP, in partnership with the farmer and other milk quality professionals, is essential, to understand the epidemiology and on-farm drivers of mastitis, to develop farm-specific action plans, and to facilitate ongoing monitoring of progress. It is vital that PVPs provide leadership, with the provision of a holistic, herd health approach to inform both prescribing and mastitis control decisions in herds under their care.
(© 2022. The Author(s).)
Databáze: MEDLINE
Externí odkaz: